The {pharmaceutical sector is rapidly exploring novel treatment methods for metabolic conditions, and the introduction of semaglutide 10mg vials represents a significant advancement . Doctors are cautiously consider the potential benefits and challenges associated with this increased potency product, particularly in relation to existing less potent